18 Malabsorption due to microbiome imbalance, gut barrier damage, chronic use of medications such as metformin and proton-pump inhibitors, and poor diet also increases the likelihood of low B12 levels
"With the recent expansion of GLP-1 RAs as an approved therapy for obesity, further investigation is warranted to assess its long-term safety and efficacy in MASLD populations." The Target RWE study underscores the potential of GLP-1 RAs as a meaningful intervention for MASLD, particularly as the interplay between metabolic diseases and liver disease rises
In contrast, the SMR method has a narrower 95% CI, potentially suggesting higher accuracy although its OR value approaches 1
Cant handle hot coffee but iced coffee tolerable
As a synthetic 39-amino acid peptide, Retatrutide (LY3437943) acts as a single-sequence multi-agonist with structural affinity for three distinct metabolic receptors: Gastric Inhibitory Polypeptide (GIP), Glucagon-Like Peptide-1 (GLP-1), and Glucagon (GCGR)
.png)
